Haixia Du

506 total citations
30 papers, 368 citations indexed

About

Haixia Du is a scholar working on Molecular Biology, Epidemiology and Complementary and alternative medicine. According to data from OpenAlex, Haixia Du has authored 30 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Epidemiology and 10 papers in Complementary and alternative medicine. Recurrent topics in Haixia Du's work include Traditional Chinese Medicine Analysis (9 papers), Influenza Virus Research Studies (4 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Haixia Du is often cited by papers focused on Traditional Chinese Medicine Analysis (9 papers), Influenza Virus Research Studies (4 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Haixia Du collaborates with scholars based in China, United Kingdom and United States. Haixia Du's co-authors include Yu He, Jiehong Yang, Huifen Zhou, Haitong Wan, Chongyu Shao, Yi-yu Lu, Xiaofei Cheng, Xiao-bin Cheng, L Y Pan and Qinsong Sheng and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

Haixia Du

27 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haixia Du China 12 171 90 72 64 53 30 368
Ming Jin China 14 201 1.2× 70 0.8× 52 0.7× 57 0.9× 45 0.8× 48 596
Zi-Hao Wang China 14 186 1.1× 59 0.7× 39 0.5× 65 1.0× 20 0.4× 37 417
Kaihuan Wang China 14 229 1.3× 120 1.3× 62 0.9× 124 1.9× 25 0.5× 23 504
Xiaojiao Duan China 15 221 1.3× 133 1.5× 76 1.1× 108 1.7× 31 0.6× 28 543
Ting-Hsu Lin Taiwan 14 202 1.2× 57 0.6× 79 1.1× 49 0.8× 12 0.2× 23 487
Jinxia Sun China 11 219 1.3× 52 0.6× 96 1.3× 57 0.9× 15 0.3× 20 423
Xiaolan Cui China 13 150 0.9× 82 0.9× 114 1.6× 76 1.2× 18 0.3× 54 525
Minyao Li China 11 228 1.3× 36 0.4× 82 1.1× 97 1.5× 21 0.4× 20 442
Gong Yang China 11 227 1.3× 49 0.5× 46 0.6× 99 1.5× 25 0.5× 23 491
Shao-Mei Huang Taiwan 11 112 0.7× 53 0.6× 55 0.8× 41 0.6× 12 0.2× 18 328

Countries citing papers authored by Haixia Du

Since Specialization
Citations

This map shows the geographic impact of Haixia Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haixia Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haixia Du more than expected).

Fields of papers citing papers by Haixia Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haixia Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haixia Du. The network helps show where Haixia Du may publish in the future.

Co-authorship network of co-authors of Haixia Du

This figure shows the co-authorship network connecting the top 25 collaborators of Haixia Du. A scholar is included among the top collaborators of Haixia Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haixia Du. Haixia Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Daojun, et al.. (2025). Chlorogenic acid inhibits virulence and resistance gene transfer in outer membrane vesicles of carbapenem-resistant Klebsiella pneumoniae. Frontiers in Pharmacology. 16. 1562096–1562096. 1 indexed citations
3.
4.
5.
Li, Xuemei, et al.. (2023). FOLR1‐stabilized β‐catenin promotes laryngeal carcinoma progression through EGFR/AKT/GSK‐3β pathway. Molecular Carcinogenesis. 63(1). 34–44. 2 indexed citations
6.
Du, Haixia, Huifen Zhou, Yu He, et al.. (2023). Yinhuapinggan granule ameliorates lung injury caused by multidrug-resistant Acinetobacter baumannii via inhibiting NF-κB/NLRP3 pathway. Heliyon. 9(11). e21871–e21871. 3 indexed citations
7.
8.
Du, Haixia, Huifen Zhou, Jiehong Yang, et al.. (2022). Screening of Antiviral Components of Yinhuapinggan Granule and Protective Effects of Yinhuapinggan Granule on MDCK Cells with Influenza A/H1N1 Virus. BioMed Research International. 2022(1). 1040129–1040129. 4 indexed citations
9.
Du, Haixia, Yu He, Jiaqi Zhu, et al.. (2022). Danhong injection alleviates cerebral ischemia-reperfusion injury by inhibiting mitochondria-dependent apoptosis pathway and improving mitochondrial function in hyperlipidemia rats. Biomedicine & Pharmacotherapy. 157. 114075–114075. 12 indexed citations
10.
11.
Zhou, Huifen, Yu He, Zhixiong Wang, et al.. (2021). Danhong injection alleviates cerebral ischemia/reperfusion injury by improving intracellular energy metabolism coupling in the ischemic penumbra. Biomedicine & Pharmacotherapy. 140. 111771–111771. 38 indexed citations
12.
Du, Haixia, Chang Li, Zhixiong Wang, et al.. (2021). Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats. Journal of Ethnopharmacology. 274. 114058–114058. 15 indexed citations
13.
Zhou, Huifen, Yu He, Haixia Du, et al.. (2021). Danhong injection enhances the therapeutic effect of mannitol on hemispheric ischemic stroke by ameliorating blood-brain barrier disruption. Biomedicine & Pharmacotherapy. 142. 112048–112048. 21 indexed citations
14.
Du, Haixia, Huifen Zhou, Jiehong Yang, et al.. (2020). Preliminary study of Yinhuapinggan granule against H1N1 influenza virus infection in mice through inhibition of apoptosis. Pharmaceutical Biology. 58(1). 979–991. 11 indexed citations
15.
He, Yu, et al.. (2020). Output Regulation and Function Optimization of Mitochondria in Eukaryotes. Frontiers in Cell and Developmental Biology. 8. 598112–598112. 7 indexed citations
16.
Zhang, Jiaxin, et al.. (2020). Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High‐Fat Diet‐Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway. Journal of Immunology Research. 2020(1). 3413186–3413186. 26 indexed citations
17.
He, Yu, Huifen Zhou, Haixia Du, et al.. (2020). Domesticated and optimized mitochondria: Mitochondrial modifications based on energetic status and cellular stress. Life Sciences. 265. 118766–118766. 6 indexed citations
18.
Du, Haixia, Chongyu Shao, Huifen Zhou, et al.. (2019). Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A. Frontiers in Pharmacology. 10. 961–961. 52 indexed citations
19.
Du, Haixia, Huifen Zhou, Haofang Wan, et al.. (2018). Antiviral effects and mechanisms of Yinhuapinggan granule against H1N1 influenza virus infection in RAW264.7 cells. Inflammopharmacology. 26(6). 1455–1467. 19 indexed citations
20.
Du, Haixia, et al.. (2016). Leukopenia and neutropenia caused by sertraline. 18(3). 220–221. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Jin Breakdown of academic impact, for papers by Zi-Hao Wang Breakdown of academic impact, for papers by Kaihuan Wang Breakdown of academic impact, for papers by Xiaojiao Duan Breakdown of academic impact, for papers by Ting-Hsu Lin Breakdown of academic impact, for papers by Jinxia Sun Breakdown of academic impact, for papers by Xiaolan Cui Breakdown of academic impact, for papers by Minyao Li Breakdown of academic impact, for papers by Gong Yang Breakdown of academic impact, for papers by Shao-Mei Huang
Rankless by CCL
2026